24th BioPharma Drug Discovery Nexus Conference

Unveiling the Future of Drug Discovery

Introduction

Welcome to the 24th BioPharma Drug Discovery Nexus Conference, set to take place on Nov 18th & 19th in the picturesque city of New Jersey, USA. Our conference agenda is carefully curated to explore the cutting-edge advancements in the field of drug discovery, offering a diverse range of tracks that delve into the latest trends and innovations.

From identifying and validating novel targets through human-centric AI to the revolutionary potential of cell and gene therapy, our comprehensive program promises to be a platform for invaluable insights, collaborative discussions, and breakthroughs that will shape the future of medicine. Join us in this captivating journey as we unravel the intricacies of drug discovery and usher in a new era of healthcare innovation.

Our Worldwide Audience

Sector

Pharma & Biotech - 76%

Service Providers - 18%

Others - 6%

Region

US East Coast - 60%

US West Coast - 25%

Europe - 15%

Job Function

Scientists - 48%

C-Level Executives - 29%

Directors - 13%

Vice Presidents - 10%

Our Invited Industry Leaders

Harpinder Saini

Sr. Scientist

Genentech

Manjunatha Shivaraju

Principal Scientist/Lab Head

Boehringer Ingelheim

Nikolaos Tezapsidis

President & CEO

Neurotez

Scott Halpern

Principal Scientist, Machine Learning/ AI

Bristol Myers Squibb

Morgan Dwyer, PhD

Territory Manager

VectorBuilder Inc.

Sunny Sharma

PMM, HPC & AI (MBA)

Fovus

Satarupa Mukherjee

R&D Leader, AI/ML

Roche

Dr. Fengbo Ren

Founder and CEO

Fovus

Mehmet Emrah Selli

Principal Scientist

Wugen

Tarek Al-Aydi

Technical Sales Specialist (NY/NJ)

NanoTemper Technologies Co.

Adwitiya Kar, Ph.D

Senior Scientist

Immunitas Therapeutics

Tengfei Yin (PhD)

AI & Digital Solutions Advisor for Biotech and Pharma

Fovus

Raluca Budiu-Predoiu

Director of Precision Medicine

AbbVie

Tuhin Das. PhD

Founder and CEO

TYSPAR Therapeutics

Daniel-Paul Bednarík, Ph.D.

Chief Technology Officer

Black Canyon Bio

Thomas Nittoli

Senior Director

Regeneron

Vikram Kansra

Founder&CEO

Vicero Bio

Xiaohua Zhu

Senior Director, DMPK

Nimbus Therapeutics

Laura Hong

Co-Founder & CEO

Ala R7

Erik S. Levy, M.S., M.S.

Senior Manager, Regional Sales and Strategy

Gator Bio, Inc.

Benny Yang

Chief Scientific Officer

Biocytogen

Alyssa (Casill) Fronk, Ph.D.

Director of Computational Biology

Envisagenics, Inc

Paulina Maria Wojnarowicz, Ph.D.

Director of Biology

Congruence Therapeutics

Amita Goel

CEO, Founder

Celltheon Corporation

Marci Newnham

East Coast and Canada Biopharma Business Development Manager

Hologic Diagenode

Siobhan Gartland, PhD

Epigenomics Application Specialist

Hologic Diagenode

Mark Budde

Co-founder and CEO

Plasmidsaurus

Justin Blethrow

Product Manager

Plasmidsaurus

Rick Ewing

VP, Head of Chemistry

Rapafusyn Pharmaceuticals

Mohamed Hassanein

Director, Translational Medicine

Pfizer

Iosif Gershteyn

Chief Executive Officer

ImmuVia

Edwin R Addison

Executive Chairman

Cloud Pharmaceuticals, Inc.

Soojin Kim

Senior Scientist

Genentech

Artem Evdokimov

VP - Head of Research

Orogen Therapeutics

Abhijat Vatsyayan

Head of Artificial Intelligence and Innovation

Taiho Oncology

Kalpesh Gupta

Director Research Automation

Moderna

Xiaole Chen

VP, Head of Biology

20n Bio

Mark Feitelson

CSO

SFA Therapeutics

Mark Tornetta

VP/Director of Biologics Discovery

Tavotek Biotherapeutics

TUHIN DAS, Ph.D.

Sr. Research Scientist

TYSPAR Therapeutics

Roelof Rongen

Chief Executive Officer, Board Director

Aeir Bio

Akihiro Furukawa

Director, Research & Technology Search & Evaluation, Global Business Development

Daiichi Sankyo

Ricardo Garcia

Head of Translational Sciences

GeneToBe

Elisha Chung

Senior Scientist

Regeneron

Sue McKinney

Chief Executive Officer | Founder

Altin Biosciences

Gregory Preston

Senior Director, Bioanalytical Development

Alexion Pharmaceuticals

Pablo Lapuerta

Chief Executive Officer

4M Therapeutics

Susan Macdonald

Senior Vice President, Nonclinical Development and Strategy

Incendia Therapeutics

Suzanne Schubbert

Director

Xencor

Alison Heick Varghese

Principal Scientist

Pfizer

Monica Jain

Director, R&D Data Science

Johnson & Johnson

Rittik Ghosh, PhD

Senior Scientist

Boehringer Ingelheim

Cheng Fang

Sr. VP of Research & Development

Annovis Bio

Benefits Of Attending The Conference

Building Meaningful Relations

Stay Current with Trends by Learning from Powerful Speakers

Connect with Influencers & in Turn, Your Target Audience

Get Fresh Ideas and Solutions for Your Business

Agenda At a Glance

10:05 - 11:35 Networking: Roundtable

12:55 - 1:35 Lunch Break Hot Buffet Lunch will be Served.

4:15 - 5:45 Afternoon Networking Session

10:05 - 11:35 Mid-Morning Networking Session: Roundtable

12:55 - 1:35 Lunch Break Hot Buffet Lunch will be Served.

4:15 - 5:45 Afternoon Networking

Testimonials

The meeting here presented new technologies, new ways of drug discoveries, new ways of thinking of how to discover drugs and I gained a lot out of it. I hope that I will be able to follow up with that in the future.

MARK FEITELSON CSO, SFA THERAPEUTICS

Thank you for inviting me to present my work at the BioPharma Nexus Conference San Diego.It was an informative & productive meeting. Highly recommended.

YU ZHOU Sr. Scientist, Novartis Gene Therapies

It was a great experience to be a part of BioPharma Nexus Conference and helped me make some new connections.

Vittal Shivva Senior Principal Scientist, Genentech

First time came in the DDN conference, the organizers did the great job setting up one to one meeting with us and the company representatives and the topics are relevant and hopeful to come back in the next year.

Jeff Goddard VP Business Development, AIT Bioscience

It was nice to be here at Drug Discovery Nexus in Munich & meet a lot of customer JDMResearch and we hope that we get a lot of feedback afterwards we go back to India.

Joy Paiza Vice President, JDM Research

We choose to sponsor the event, we are one of the sponsors overall this has been very good conference, the audience was very relevant, the talks were exciting and provided a lot of knowledge

Satish Nagaraj Associate Vice President, Business Development, Jubilant Biosys

Networking was great. Information of talks was informative and the agenda was good.

J. T. Kaminski Director, IDBS

Shout out to BioPharma Nexus Conference for the opportunity to present & making new business connections. Wonderful conference with very lively discussion.

Kiel Jones Business Development Manager, Malvern Panalytical

It was a great privilege to participate in BioPharma Nexus Conference San Diego and meet so many great minds from the industry.

David Li, PhD Vice President of Technology, Operation and Support, MedChemExpress LLC

My overall experience at the conference was very good. The event was very well organized, and I have no suggestions for areas of improvement. I am willing to attend upcoming BioPharma Nexus Conferences and am inclined to recommend this conference to my colleagues and industry leaders.

Qiurong Wang Regional Director of BD, Biocytogen

Our experience with this event was outstanding and met the right decision makers. The flawless execution was certainly evident throughout the 2 days we spent with your team. I would highly recommend it to peers.

Tarek Al-Aydi Head of Business Development, NanoTemper Technologies